000 | 01601 a2200481 4500 | ||
---|---|---|---|
005 | 20250513162536.0 | ||
264 | 0 | _c19990405 | |
008 | 199904s 0 0 eng d | ||
022 | _a0960-894X | ||
024 | 7 |
_a10.1016/s0960-894x(98)00653-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, X | |
245 | 0 | 0 |
_aPotent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _cDec 1998 |
||
300 |
_a3531-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-HIV Agents _xchemical synthesis |
650 | 0 | 4 | _aBlood |
650 | 0 | 4 | _aCytochrome P-450 CYP3A |
650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
650 | 0 | 4 |
_aHIV _xdrug effects |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aMicrosomes, Liver _xenzymology |
650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
650 | 0 | 4 |
_aPiperazines _xchemical synthesis |
700 | 1 | _aKempf, D J | |
700 | 1 | _aSham, H L | |
700 | 1 | _aGreen, B E | |
700 | 1 | _aMolla, A | |
700 | 1 | _aKorneyeva, M | |
700 | 1 | _aVasavanonda, S | |
700 | 1 | _aWideburg, N E | |
700 | 1 | _aSaldivar, A | |
700 | 1 | _aMarsh, K C | |
700 | 1 | _aMcDonald, E | |
700 | 1 | _aNorbeck, D W | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 8 _gno. 24 _gp. 3531-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(98)00653-2 _zAvailable from publisher's website |
999 |
_c9896047 _d9896047 |